TScan Therapeutics, Inc.·4

Dec 8, 8:20 AM ET

Woods Keith 4

4 · TScan Therapeutics, Inc. · Filed Dec 8, 2023

Insider Transaction Report

Form 4
Period: 2023-12-06
Woods Keith
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-12-06+17,50017,500 total
    Exercise: $6.74Exp: 2033-12-05Voting Common Stock (17,500 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) December 6, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4